HIV and STIs: Hot Topics

The presentation focuses on the increase of STIs in the United States, particularly among high-risk groups such as men who have sex with men (MSM) and transgender individuals. It discusses the epidemiology, diagnosis, treatment, and prevention strategies for STIs like gonorrhea, chlamydia, and syphilis, with an emphasis on the effectiveness of the new biomedical strategy, DoxyPEP (Doxycycline Post-Exposure Prophylaxis). The speaker recounts a concerning rise in gonorrhea and syphilis cases despite some temporary drops following the COVID-19 pandemic. Key points include the importance of screening high-risk populations, the use of nucleic acid amplification tests (NAATs) for accurate diagnosis, and challenges such as antibiotic resistance in gonorrhea treatment. Breakthrough mpox cases post-vaccination are also mentioned, along with cases illustrating the manifestations and treatment of STIs, emphasizing tailored approaches based on sexual history and symptoms. DoxyPEP has shown promising results in reducing STI rates among MSM, although its efficacy in cisgender women remains uncertain due to previous study results. Preventive recommendations include regular screenings for specific populations and the necessity of treating infections promptly to avoid severe complications.